Dick L. Sherman
Corporate Secretary at TETRALOGIC PHARMACEUTICALS CORPORATION
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Patrick C. Hutchison | M | 66 | 10 years | |
| Laurence Knutson | M | - |
Hawaii Biotech, Inc.
 Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
| Winston Churchill | M | 83 |
SCP Private Equity Partners
 SCP Private Equity Partners Investment ManagersFinance SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania. | 28 years |
| Danielle Kelly | F | - |
SCP Private Equity Partners
SCP Private Equity Partners Investment ManagersFinance SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania. | 17 years |
| Jennifer Murata | F | - |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
| Mark Bogart | M | - |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
| David E. Clements | M | - |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | 37 years |
| Enrique Carrazana | M | 62 |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
| Michele L. Yelmene | F | 60 |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
| John Keane | M | 80 |
SCP Private Equity Partners
SCP Private Equity Partners Investment ManagersFinance SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania. | - |
| Chuck Freyer | M | - |
SCP Private Equity Partners
SCP Private Equity Partners Investment ManagersFinance SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania. | 24 years |
| Dennis P. Ferry | M | - |
SCP Private Equity Partners
SCP Private Equity Partners Investment ManagersFinance SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania. | 24 years |
| Robert J. Robinson | M | - |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
| Debra R. Guerin Beresini | F | - |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
| Wayne Weisman | M | 68 |
SCP Private Equity Partners
SCP Private Equity Partners Investment ManagersFinance SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania. | 28 years |
| Roger Carolin | M | 68 |
SCP Private Equity Partners
SCP Private Equity Partners Investment ManagersFinance SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania. | 21 years |
| Thomas G. Rebar | M | 61 |
SCP Private Equity Partners
SCP Private Equity Partners Investment ManagersFinance SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania. | 28 years |
| Jonathan A. Barie | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Geoffrey Michael Lee | M | 62 | 13 years | |
| Howard Louie | M | 64 | 13 years | |
| Mack Gill | M | 72 | 13 years | |
| Garth Greenham | M | - | 4 years | |
| Dragan Cicic | M | 60 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | - |
| J. Buchi | M | 69 | 3 years | |
| Vinod Gupta | M | 78 |
University of Nebraska
| 3 years |
| Alok Singh | M | 67 |
New York University
| 5 years |
| Marcella LoCastro | F | 72 | 1 years | |
| Brenda D. Gavin | M | 76 | 8 years | |
| Jim Woody | M | 81 | 9 years | |
| John V. Talley | M | 68 |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | 1 years |
| Bill P. Sarubbi | M | - |
New York University
| 4 years |
| Patrick L. Vaccaro | M | - |
New York University
| 12 years |
| Fabio M. Banducci | M | - | 6 years | |
| George Christopher Logush | M | 79 |
New York University
| 3 years |
| Louis E. Black | M | - |
New York University
| 7 years |
| Kenneth W. Munoz | M | - |
New York University
| 7 years |
| Aurora Cassirer | F | 72 |
New York University
| 7 years |
| Richard Cuccioli | M | - |
New York University
| 5 years |
| Christopher Morris | M | - | 1 years | |
| Martin Murphy | M | 81 |
New York University
| 3 years |
| Doug Harman | M | 76 |
University of Nebraska
| 13 years |
| Basil Livanos | M | - |
New York University
| 5 years |
| Doug Onsi | M | 55 | 4 years | |
| Harvey Beker | M | 70 |
New York University
| 5 years |
| John Whitney | M | - |
University of Nebraska
| 5 years |
| Patrick E. Quinn | M | 77 |
University of Nebraska
| 7 years |
| Mary Gray | M | 71 | 2 years | |
| Arthur Kirsch | M | 72 | 1 years | |
| Lesley Russell | M | 63 | 3 years | |
| Jerry Milton Williams | M | 83 |
University of Nebraska
| - |
| Jeffrey D. Saper | M | - |
New York University
| 7 years |
| Michael Steinmetz | M | 75 | 5 years | |
| Michael Kishbauch | M | 75 | 2 years | |
| Pete Meyers | M | 55 | 3 years | |
| Douglas Reed | M | 70 | 6 years | |
| Jeffrey E. Curtiss | M | 75 |
University of Nebraska
| 5 years |
| Martin M. Goldwyn | M | 72 |
New York University
| 7 years |
| James E. Goldschmidt | M | - | 6 years | |
| Adam Blumenstein | M | 77 |
New York University
| 4 years |
| Bruce Siegel | M | - |
New York University
| 3 years |
| Thomas W. Hyland | M | - |
New York University
| 3 years |
| Kura Mohammed | M | - |
New York University
| 4 years |
| David X. Martin | M | - |
New York University
| 2 years |
| Frank W. Oldham | M | - |
New York University
| 5 years |
| John Raymont | M | - |
New York University
| 4 years |
| Siu Lau | M | 71 |
New York University
| 4 years |
| Hernan Grant Welch | M | - |
New York University
| 2 years |
| Robert J. Groden | M | - |
New York University
| 2 years |
| Kenneth J. Blank | M | - |
New York University
| 4 years |
| Peter Klaich | M | - |
New York University
| 4 years |
| Yoram Kinberg | M | - |
New York University
| 3 years |
| Willis J. Goldsmith | M | - |
New York University
| 3 years |
| Alan Joseph Brod | M | - |
New York University
| 4 years |
| Rudolph W. Giuliani | M | - |
New York University
| 4 years |
| Roger A. Goldman | M | - |
New York University
| 3 years |
| Les B. Levi | M | - |
New York University
| 4 years |
| Mitchell S. Landis | M | 73 |
New York University
| 4 years |
| Paula Kruger | F | 73 |
New York University
| 4 years |
| Kenneth J. Frank | M | 77 |
New York University
| 3 years |
| Perry G. Fish | M | 81 |
New York University
| 3 years |
| Jan Nicholson | F | 79 |
New York University
| 1 years |
| Anne Tatlock | F | 84 |
New York University
| 1 years |
| Sally G. Narodick | F | 78 |
New York University
| 2 years |
| Jerry M. Seslowe | M | 78 |
New York University
| 3 years |
| Christopher M. Miner | M | 72 |
New York University
| 4 years |
| Michael C. Markovitz | M | 70 |
New York University
| 4 years |
| Andrew B. Derman | M | - |
New York University
| 4 years |
| Judah C. Sommer | M | - |
New York University
| 3 years |
| Gin Chung Seto | M | 76 |
New York University
| 2 years |
| Fred N. Shapiro | M | - |
New York University
| 4 years |
| Thomas Sidlik | M | 73 |
New York University
| 4 years |
| Michael Stanley Hoffman | M | - |
New York University
| 4 years |
| Evan Chesler | M | - |
New York University
| 4 years |
| Charles P. Hapcook | M | - |
New York University
| 3 years |
| Irving Bailey | M | 83 |
New York University
| 5 years |
| Steven P. Florsheim | M | 82 |
New York University
| 3 years |
| Henry Weingarten | M | - |
New York University
| 4 years |
| Philip H. Werner | M | - |
New York University
| 4 years |
| Earl Masters Foster | M | - |
New York University
| 3 years |
| Leonard Singer | M | - |
New York University
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 95.00% |
| Canada | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dick L. Sherman
- Personal Network